This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In this scientific statement, we examined the technology-enabled interventions that address cardiovascular health behaviors from adolescence to adulthood in populations most affected by health disparities. We used a broad definition of technology, including wearables, applications, and telehealth, for behavior tracking.
These insights are made accessible to cardiology care network and payer partners, driving informed decision-making and improved outcomes. will supercharge Karoo Health's MoC, allowing more patients to experience better outcomes and lower cost of care. critical for timely interventions in cardiac VBC.
Strong, flexible, gel-like tubes -- created using a novel 3D printing technology -- could improve outcomes for heart bypass patients by replacing the human and synthetic veins currently used in surgery to re-route blood flow, experts say.
We continue to be amazed by the imaging teams around the country who commit so much of themselves to improving patient outcomes. Insights into technology and what the future holds for MRI, CT and more were among our most viewed articles by far. What a year it’s been! We’ll continue to bring you these insights and many more in 2024.
Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. The CaRi-Heart technology is in clinical use in the UK, European Union, and Australia.
By leveraging Anumana's ECG-AI algorithms, developed and validated in collaboration with Mayo Clinic, this initiative aims to enhance InfoBionic.Ai’s MoMe ARC Platform’s ability to detect and intervene in cardiac diseases earlier in the remote patient monitoring setting, with the potential to improve patient outcomes.
This critical information empowers physicians to select the most suitable endovascular therapeutic approach, thereby mitigating complications, avoiding embolization, and enhancing long-term treatment outcomes. Koen Deloose , Head of Vascular Surgery at AZ Sint-Blasius Hospital, and principal investigator of the SEPARATE clinical trial.
Strong, flexible, gel-like tubes—created using a novel 3D printing technology—could improve outcomes for heart bypass patients by replacing the human and synthetic veins currently used in surgery to re-route blood flow, experts say.
Food and Drug Administration’s ( FDA ) Breakthrough Device Designation for their ECGvision-TTR Technology for early detection of ATTR-Cardiomyopathy. The technology was developed in the Cardiovascular Data Science (CarDS) Lab by Dr. Rohan Khera , with Veer Sangha , a Yale graduate and Rhodes Scholar.
Imagine having a digital carbon copy of yourself that physicians could use to predict long-term risks for disease, assess how your body may respond to treatment, and simulate surgeries in advance.
In the fast-evolving world of medical technology, continuous glucose monitors (CGMs) are making headlines. With OTC approval, these devices are now more accessible to a broader range of patients, empowering people to understand the impact of diet and potentially improving health outcomes. What is a Continuous Glucose Monitor?
IVF treatment and pregnancy outcomes were not significantly different between patients with and without liver disease who received assisted reproductive technology treatment.
milla1cf Wed, 01/03/2024 - 12:09 January 3, 2024 — iRhythm Technologies, Inc. , The EU MDR is arguably one of the most stringent regulatory frameworks for product approvals globally that ensures medical devices meet the rigorous standards for healthcare technologies,” said Quentin Blackford, iRhythm President and Chief Executive Officer.
This narrative review aims to evaluate strategies for reducing door-to-balloon (D2B) time in ST-elevation myocardial infarction (STEMI) patients, focusing on pre-hospital, in-hospital, and technological innovations, as well as addressing challenges to ensure sustainability.
(MedPage Today) -- ORLANDO -- Technologic advances aren't fulfilling their promise for improving diabetes or overall health outcomes in the U.S., We are wowing the world in technology -- much of. argued FDA Commissioner Robert Califf, MD. "We
Lead researcher Dr Pankaj Garg , of the University of East Anglia’s Norwich Medical School and a consultant cardiologist at the Norfolk and Norwich University Hospital, heads up a team of researchers who have pioneered innovative and revolutionary 4D MRI imaging technology.
In today's blog, we'll explore the transformative impact of technology on medical education and why continuous learning is crucial for every doctor's success. The Technological Renaissance in Medicine: The realm of medicine is experiencing a renaissance, with cutting-edge technologies reshaping the way healthcare is delivered.
ObjectivesRegistered, prospective, multicenter study of the short-term clinical outcomes of a novel transcatheter aortic valve system (Xcor system, Saint Medical Technology, Inc., Procedural, in-hospital, and follow-up clinical outcomes were evaluated after procedures.ResultsThe average age of the 130 patients was 71.24.4
In the age of technology, wearable devices have revolutionized how we approach health and wellness. This blog explores the ways wearable technology can help track heart health, the advantages it offers, and how it contributes to better outcomes for those requiring surgical intervention.
Ablation index (AI)-guided pulmonary vein isolation (PVI) has enhanced procedural outcomes for atrial fibrillation (AF).1 1 However, patients with persistent AF present higher recurrence rates due to advanced atrial remodeling,2-3 represented by the left atrial low voltage area (LVA), compared to those with paroxysmal AF.
This transition reflects a growing focus on prioritizing patient outcomes over the volume of services provided. By emphasizing healthcare efficiency and improved outcomes, value-based care is transforming the way cardiology practices deliver patient care, especially when addressing chronic conditions common in cardiac patients.
In the ever-evolving landscape of medical education, technology has emerged as a powerful ally, revolutionizing the way doctors across various fields of medicine learn, practice, and stay updated. Let's delve into how technology is reshaping medical education and benefiting doctors in different specialties. www.adncoe.com
In the ever-evolving landscape of medical education, technology has emerged as a powerful ally, revolutionizing the way doctors across various fields of medicine learn, practice, and stay updated. Let's delve into how technology is reshaping medical education and benefiting doctors in different specialties. www.adncoe.com
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results. So, again, innovation is great.
These results pave the way for integration into wearable technologies, allowing early interventions and better patient outcomes. It gives early warnings on average 30 minutes before onset, with an accuracy of around 80%.
milla1cf Tue, 04/23/2024 - 16:03 April 23, 2024 — CDL Nuclear Technologies , a pioneer in advanced diagnostic solutions, is proud to announce the launch of its latest innovation: the Mobile dedicated Cardiac PET/CT Trailer. CDL provides this service in compliance with all healthcare regulations. webflow.io
In the dynamic realm of healthcare technology, cardiovascular information systems (CVIS) stand at the forefront, facilitating streamlined operations, enhanced patient care and efficient data management within cardiovascular departments.
The presenter will examine how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures. Additionally, Schalit–Cohen will delve into the realm of AI technologies and their potential to support structural heart workflows. as well as customer satisfaction.
The NeuSight PET-CT advanced technology sets a new standard in imaging and diagnostic precision, patient comfort, and operational efficiency for nuclear cardiology practices and hospitals. Proprietary IPIE technology improves spatial resolution and data accuracy.
Penumbras continuous advancements provide a comprehensive portfolio for physicians to treat a wider range of patients and improve patient outcomes. Innovative Valve Technology Element features the HemoLockValve System, designed to ensure hemostasis through dual-valve engineering. CAT TM 16 catheter.
A new Intelligent thrombo-suction catheter system , is being introduced for treatment of acute pulmonary embolism.This device regulates the force with which thrombus is sucked , with less injury and bleeding and better outcomes. Human studies & Evidence The experience from this device was presented in ESC 2024 London.
a pioneering medical technology company specializing in cardiovascular interventional devices, today announced that its groundbreaking Acolyte Image Guided Crossing and Re-Entry Catheter System has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ).
Procedures that previously required the use of two different devices can now be performed in a single procedure using a single device, simplifying workflows and procedures and potentially reducing the risk and improving outcomes for patients who might otherwise face multiple complex interventions. Patients will be followed for 12 months.
Methods and analysis The Percutaneous coronary intervention using Assisted Robotic TechnologY (PARTY) trial is a single-centre, prospective, randomised, open-label clinical trial comparing R-PCI to M-PCI. The primary outcome is radiation exposure to the patient, as measured by personal radiation dosimeters.
ObjectivesTelenursing in cardiac care leverages technology to support self-care and optimize outcomes for heart failure patients during and beyond the pandemic.
Positron joins forces with the coalitions founding members, Bracco Diagnostics , CDL Nuclear Technologies and Siemens Healthcare who have come together to promote federal policies that advance health outcomes for patients with cardiovascular disease and improve the availability of cardiac PET diagnostics throughout the United States.
has partnered with the Advanced Cardiac Therapies Improving Outcomes Network (ACTION) 1 to provide the real-world data necessary to support on-label use of Impella 5.5 and Impella CP enable heart recovery as part of the world's smallest heart pump platform. Johnson & Johnson MedTech (Abiomed, Inc.)
Sonic Lumen Tomography (SLT) technology addresses a critical unmet need for vascular specialists by providing automatic, real-time, accurate, numeric measurements of the flow lumen of blood vessels without the complexities of image interpretation.
milla1cf Tue, 04/16/2024 - 12:40 April 16, 2024 — Vivasure Medical , a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced it has treated the first large bore venous patient with the PerQseal Elite vascular closure system, a sutureless and fully bioresorbable large-bore vessel closure device.
a medical technology company focused on transforming cardiac care through the power of personalized insights, announced significant developments for the use of artificial intelligence (AI) applied to its proprietary vectorelectrocardiography (VECG) technology, including the addition of new leadership and advisory roles.
In organ transplantation, an extended criteria donor is defined as having perceived risk factors linked to poor subsequent outcomes, for example, those with age >55 or ischemic times exceeding 4 hours, which sometimes leads to rejection of the donor organ.
As patient expectations rise and technology advances, engaging patients effectively has never been more crucial to delivering top-tier care. For cardiology practices, choosing the right patient engagement platform is vital for improving outcomes, optimizing workflow, and maintaining a competitive edge. GEMMS ONE V7.8,
The IVI is working towards a transition to a new kind of wellness and health system fueled and empowered by digital technologies. This concept, reported the company, is about using technology to develop preventative approaches that are 10 times more impactful than the current available solution.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
74 
Let's personalize your content